News

World medical society is worried about the problem of the rheumatic diseases which, according to the statistics, stand first on the rating list of the “human population diseases” differing with the high level of extension and variety.

The unique opportunity was presented to the participants of the scientific-practical conference on “Innovations in the diagnostics and medical treatment of the rheumatic diseases” which took place on the 23-24^th of April in Almaty to discuss the most important problems in the medical treatment and diagnostics of rheumatic diseases along with the European leading specialists in the field of such kind diseases curing. The event contained plenary meetings, lectures of the honourable speakers, practical master classes on contemporary diagnostics of the rheumatic diseases with the participation of the European leading specialists and also the round-table conference.

There were discussed the actual topics such as treatment of the systemic lupus erythematosus and lupus nephritis, aspects of the preparations security, international recommendations for the treatment of rheumatological patients, contemporary aspects of the glucocorticoid therapy of the rheumatic diseases, genomics and metabolomics of the rheumatoid arthritis and others.

“VIVA PHARM” Company has also participated in the conference presenting the  glucocorticoid drug “Metipred” (methylprednisolone) which has an anti-inflammatory, immunosuppressive and antiallergic effect. The drug exercises the influence upon the carbohydrate, protein, lipidic metabolism and also reduces the quality of immunocompetent cells in the area of inflammation and vasodilation, stabilizes lysosomal membranes, decreases the production of prostaglandins and leukotrienes.

Methylprednisoline is prescribed for the therapy of the collagenoses (including the systemic lupus erythematosus, rheumatic arthritis, seronegative spondylarthritis, Sjogren disease, dermatopyomyositis) allergic reactions, anaphylactic shock,   bronchial asthma of the difficult treatment, colitis ulcerative, glomerulonephritis, viral hepatitis, eczema and neurodermatitis and also in case of the leukemia, lymphoma, myeloma, lung cancer (in combination with the cytostatic drugs) and at the reduction of nausea and vomiting arising on the ground of  cytostatic therapy.

Occurred scientific-practical conference had a great importance for rising of professional skills level of Kazakh rheumatologists and regarding the qualified medical services rendered to population in accordance with world standards.